FDA approves Roche’s VENTANA ALK D5F3 CDx Assay for use on the VENTANA BenchMark ULTRA system

TUCSON Ariz. Nov. 7 2016 PRNewswire Roche SIX RO ROG; OTCQXRHHBY announced today that the U.S. Food and Drug Administration FDA has approved the VENTANA ALK D5F3 CDx Assay1 for use on the VENTANA Be…
Read the full story: Bioportfolio Biomarker News